SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001618835-18-000061
Filing Date
2018-08-02
Accepted
2018-08-02 06:32:55
Documents
71
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q evfm-630201810xq.htm 10-Q 996662
2 EXHIBIT 10.7 evfm-2018inducementequityp.htm EX-10.7 206760
3 EXHIBIT 10.8 evfm-2018noticeofgrantindu.htm EX-10.8 78382
4 EXHIBIT 31.1 evfm-6302018ex311.htm EX-31.1 22641
5 EXHIBIT 31.2 evfm-6302018ex312.htm EX-31.2 22879
6 EXHIBIT 32.1 evfm-6302018ex321.htm EX-32.1 15097
  Complete submission text file 0001618835-18-000061.txt   6377978

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT evfm-20180630.xml EX-101.INS 1013816
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT evfm-20180630.xsd EX-101.SCH 54785
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT evfm-20180630_cal.xml EX-101.CAL 68032
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT evfm-20180630_def.xml EX-101.DEF 383940
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT evfm-20180630_lab.xml EX-101.LAB 668216
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT evfm-20180630_pre.xml EX-101.PRE 464667
Mailing Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130
Business Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130 (858) 550-1900
Evofem Biosciences, Inc. (Filer) CIK: 0001618835 (see all company filings)

IRS No.: 208527075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36754 | Film No.: 18986541
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1